DC Investments Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-1,924
Closed -$275K – 194
2020
Q2
$275K Sell
1,924
-1,651
-46% -$228K 0.1% 248
2020
Q1
$388K Buy
3,575
+997
+39% +$144K 0.31% 121
2019
Q4
$375K Buy
2,578
+44
+2% +$6.35K 0.29% 167
2019
Q3
$366K Sell
2,534
-43
-2% -$6.28K 0.21% 211
2019
Q2
$383K Sell
2,577
-998
-28% -$139K 0.21% 200
2019
Q1
$470K Buy
+3,575
New +$440K 0.3% 163
2018
Q4
– Sell
-3,603
Closed -$538K – 280
2018
Q3
$538K Sell
3,603
-139
-4% -$21.1K 0.36% 125
2018
Q2
$577K Buy
3,742
+77
+2% +$11.6K 0.37% 81
2018
Q1
$509K Sell
3,665
-2,213
-38% -$325K 0.34% 109
2017
Q4
$806K Buy
+5,878
New +$777K 0.33% 70

Other funds holding LH

DC Investments Management's LH Position: Q3 2020 in Review

DC Investments Management sold out of Labcorp (LH) in Q3 2020, closing a stake of 1,924 shares — an estimated $275K sold.

DC Investments Management first reported a position in LH in Q4 2017 and held it in 10 quarters. The position peaked at $806K in Q4 2017. 810 funds tracked by Wall St. Rank hold LH as of Q3 2020.

  • DC Investments Management reported no remaining Labcorp position as of Q3 2020 after selling out during the quarter.
  • DC Investments Management sold 1,924 Labcorp shares in Q3 2020, an estimated $275K.
  • DC Investments Management first reported a position in Labcorp in Q4 2017 and held it in 10 quarters.
  • DC Investments Management's Labcorp position peaked at $806K in Q4 2017.
  • 810 funds tracked by Wall St. Rank held Labcorp as of Q3 2020.

Based on DC Investments Management's 13F filing for Q3 2020, filed 4 Nov 2020.